Skip to main content

Prescription medicine

Glutamine Brand names: Endari

Glutamine (Endari) is a prescription medicine. FDA's NDC Directory lists it from 3 generic labelers.

  • Generic listed

Check it at the source: the glutamine FDA label on DailyMed (effective June 20, 2025); every glutamine label on DailyMed.

Highlights of the record

FDA label of June 20, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Endari is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.

Forms and strengths

  • 5 g

Powder for solution.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
4 of which 3 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
1 since 2013 0 Class I among all firms' recalls; latest September 10, 2018; 3 more by firms not listed as its makers
FAERS reports
4,739 through July 30, 2026

What is glutamine used for?

From the label: indications and usage

Endari is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older. ENDARI is an amino acid indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.

FDA pharmacologic class: Amino Acid.

Source: FDA drug label (Endari), Emmaus Medical, Inc., effective June 20, 2025 (SPL set d5a783f4-12ef-4326-8faa-40018e45ba3b), via openFDA; the full label on DailyMed

Is there a generic for glutamine (Endari)?

No generic glutamine is approved (Drugs@FDA, October 8, 2026).

FDA's NDC Directory lists glutamine from 3 labelers under a generic (ANDA) application and from 1 brand labeler. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

Has glutamine been recalled?

The FDA's Enforcement Report lists 4 recalls naming glutamine since 2013: 0 Class I (the most serious), 4 Class II, 0 Class III; 1 still ongoing. 3 of them are by firms that FDA's NDC Directory does not list as a maker of glutamine and that hold no application for it in Drugs@FDA, such as compounding pharmacies or bulk-ingredient suppliers; the recall notice names the product recalled. A recall names products and lots, not every product of the medicine.

StartedClassCompanyReason
September 10, 2018Class IIPharm D Solutions, LLCLack of Assurance of Sterility
September 27, 2017Class IIUnited Pharmacy not a listed makerCGMP Deviations; FDA analysis deterrmined that the product does not contain glutamine and two unknown impurities were observed
November 17, 2016Class IITri-Coast Pharmacy not a listed makerLack of Assurance of Sterility
July 26, 2013Class IIBeacon Hill Medical Pharmacy, P.C. not a listed makerLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026

What does the glutamine label say about other medicines?

The glutamine label names no other medicine on this site. The labels of 2 other medicines name glutamine. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Other labels that name glutamine

Check glutamine against other medicines

Source: FDA drug label (Endari), Emmaus Medical, Inc., effective June 20, 2025 (SPL set d5a783f4-12ef-4326-8faa-40018e45ba3b), via openFDA; the full label on DailyMed

What do FAERS reports show for glutamine?

The FDA Adverse Event Reporting System holds 4,739 reports that list glutamine among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 142 are coded as a death and 1,787 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Reports received each year

The most reported reactions

  • Sickle Cell Anaemia With Crisis1,646
  • Product Dose Omission Issue (a use or a product term, not a reaction)667
  • Pain293
  • Nausea (named in the label)277
  • Product Dose Omission (a use or a product term, not a reaction)272
  • Headache (named in the label)231
  • Diarrhoea213
  • Hospitalisation (an outcome recorded in the report)189

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other amino acids
the pharmacologic class, with prices and generics
Glutamine side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other